bioAffinity Technologies (BIAF) Change in Receivables (2022 - 2026)
bioAffinity Technologies (BIAF) reported Change in Receivables of $143274.0 for Q1 2026, up 181.66% year-over-year from $50868.4 in Q1 2025, and up 54.1% quarter-over-quarter from $92972.0 in Q4 2025.
bioAffinity Technologies (BIAF) Change in Receivables (2022 - 2026) Analysis & Trends
bioAffinity Technologies (BIAF) has 5 years of Change in Receivables data on file, last reported at $143274.0 in Q1 2026.
- Change in Receivables for Q1 2026 came in at $143274.0, up 181.66% year-over-year; the trailing twelve-month figure through Mar 2026 was -$278508.0 (down 74.21% YoY), and the FY2025 annual result was -$597242.0, down 282.35% from the prior year.
- Change in Receivables advanced to $143274.0 in Q1 2026 per BIAF's latest filing, from $92972.0 in the prior quarter.
- Over five years, Change in Receivables peaked at $472017.0 in Q2 2024 and troughed at -$541875.0 in Q2 2025.
- A 5-year average of -$25226.2 and a median of $956.0 in 2022 frame the typical range for Change in Receivables.
- The sharpest annual moves came in 2023 and 2024: Change in Receivables slumped 42949.02% in 2023, then jumped 57880.48% in 2024.
- A 5-year view of Change in Receivables shows it stood at $559.0 in 2022, then tumbled by 42949.02% to -$239526.0 in 2023, then increased by 21.53% to -$187964.0 in 2024, then surged by 149.46% to $92972.0 in 2025, then soared by 54.1% to $143274.0 in 2026.
- Business Quant data shows BIAF's Change in Receivables at $143274.0 in Q1 2026, $92972.0 in Q4 2025, and $27121.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | 533.00 Mn |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | - |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | -66.00 Mn |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 56.81 Mn |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | -12.00 Mn |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | 121.07 Mn |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | - |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | -118.00 Mn |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | -65.11 Mn |
| 10 | bioAffinity Technologies | 2.08 Mn | -1.02 Mn | - | 143,274.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 143,274.00 |
| Mar 31, 2026 | 143,274.00 |
| Dec 31, 2025 | 92,972.00 |
| Dec 31, 2025 | 92,972.00 |
| Sep 30, 2025 | 27,121.00 |
| Sep 30, 2025 | 27,121.00 |
| Jun 30, 2025 | -541,875.00 |
| Jun 30, 2025 | -541,875.00 |
| Mar 31, 2025 | -175,460.00 |
| Mar 31, 2025 | -175,460.00 |
| Dec 31, 2024 | -187,964.00 |
| Dec 31, 2024 | -187,964.00 |
| Sep 30, 2024 | -268,458.00 |
| Sep 30, 2024 | -268,458.00 |
| Jun 30, 2024 | 472,017.00 |
| Jun 30, 2024 | 472,017.00 |
| Mar 31, 2024 | 311,935.00 |
| Mar 31, 2024 | 311,935.00 |
| Dec 31, 2023 | -239,526.00 |
| Dec 31, 2023 | -239,526.00 |